Neurocycle Therapeutics, a clinical-stage pharmaceutical company, is dedicated to improving the lives of patients dealing with devastating neurologic, neuropsychiatric, and neurodevelopmental disorders. With a focus on precision neuroscience, their transformative therapies address the complex neurocircuitry and molecular mechanisms underlying disorders of the nervous system. Founded in 2019, Neurocycle Therapeutics strives to become a leader in neuroscience by rapidly advancing their innovative, precision-targeted therapeutics.

Their innovative pipeline is the result of strong partnerships and internal discovery capabilities, highlighting their commitment to achieving their mission. With a scientific expertise in molecular mechanisms and a deep understanding of the needs of patients with life-limiting disorders, Neurocycle Therapeutics is poised to develop new treatments that have the potential to make a significant impact on patients' lives